Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 7Leukemia, Myeloid, Acute 6Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myelomonocytic, Chronic 3Hodgkin Disease 3Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2Leukemia 2Hemoglobinopathies 2Congenital Abnormalities 2Thalassemia 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Immunologic Deficiency Syndromes 1Histiocytosis, Langerhans-Cell 1

Interventions

Cyclophosphamide 20fludarabine phosphate 16Busulfan 13Antilymphocyte Serum 13Peripheral Blood Stem Cell Transplantation 12Mycophenolic Acid 12Cyclosporine 11Tacrolimus 9Methylprednisolone 8Filgrastim 8Epoetin Alfa 8Cord Blood Stem Cell Transplantation 7Whole-Body Irradiation 6Radiotherapy 6Methotrexate 6Melphalan 5Etoposide 4Darbepoetin alfa 4Cytarabine 4fludarabine 3Therapeutics 2Immunoenzyme Techniques 2Granulocyte Colony-Stimulating Factor 2Carmustine 2tipifarnib 1sargramostim 1ferrous sulfate 1ferric gluconate 1epoetin beta 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Clofarabine × Classical hematology × Clear all
NCT01500161 2013-11-25

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Texas Oncology Cancer Center

Phase 2 Terminated
1 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡